| I think you may be operating under the assumption that the extremely expensive price tag will need to be repeated for each patient. In reality, as this process becomes more mature it is going to become inexpensive. The reduction in cost will almost certainly be similar to reduction in cost needed to sequence an individual's genome, which has fallen from tens of millions to hundreds of dollars. The only catch is that we have to spend money to get there. Another catch is that the nations who underwrite this research will turn millions in investments into trillions in dividends and the stingy or poor will be left in the cold. Seeing that private enterprise is only good at taking publicly-funded work and patenting it, and that in the absence of public funding nothing ever gets invented, we should be all-in on this. edit: it's apropos that you mentioned obesity because GLP-1 drugs are the direct, irrefutable, product of spending at government labs. edit2: specifically, a single government scientist playing around with lizard saliva in the 1970s because he thought it was interesting. |
There's no evidence to support that gene therapy will ever be inexpensive. We can merely say that the process may become less shockingly expensive.